Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucosal Immune Responses Against Gonorrhea Following Meningococcal Immunization
NCT04722003Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal group B vaccine in gonorrhea, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2021; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT04722003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04722003.